Collaboration guides each step of our work, especially in how we fund promising ALS research. For that reason, the Target ALS Corporate Council was created to extend our partnerships across industries, with new perspectives. We are excited to announce this new...
Silence ALS initiative will offer an integrated solution to identify, support and potentially treat nano-rare ALS patients. n-Lorem foundation and Columbia University receive a founding donation from Target ALS of $400,000 to formalize the Silence ALS initiative and...
The organizations also praise an unsung hero and recognize groundbreakers including researchers, philanthropists, and patients Target ALS and Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced Merit E. Cudkowicz, Chief of the Neurology Department at...
Collaboration, with Support from the ADDF’s Diagnostics Accelerator, Will Create Funding Opportunities to Advance Potential Biomarkers in Related Neurodegenerative Diseases. The Alzheimer’s Drug Discovery Foundation (ADDF) and Target ALS announced today a new...
Award Will Recognize Members of the ALS Community Who Embrace a Courageous Spirit Target ALS and Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the establishment of the inaugural Target ALS Rebecca Luker Courage Award. The award will spotlight...
